Andrea Randell
Internal Medicine · Tallahassee, FLNPI 1508869421
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $716 and has fallen 98.2% since, to $13 in 2024.
Across 164 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$322
- Astellas Pharma US Inc$311
- Pfizer$242
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$174
- Sanofi-aventis U.S. LLC$145
- Merck$138
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,37699%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $322 |
| Astellas Pharma US Inc | 21 | $311 |
| Pfizer | 17 | $242 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $174 |
| Sanofi-aventis U.S. LLC | 10 | $145 |
| Merck | 10 | $138 |
| Boehringer Ingelheim | 7 | $133 |
| Amgen | 9 | $130 |
| Kowa Pharmaceuticals America, Inc. | 9 | $130 |
| AstraZeneca | 10 | $122 |
| Lilly USA, LLC | 9 | $115 |
| Amarin Pharma, Inc. | 6 | $101 |
| GSK | 5 | $67 |
| Bayer | 3 | $41 |
| Johnson & Johnson | 2 | $35 |
| Nestle Healthcare Nutrition Inc. | 2 | $34 |
| Almatica Pharma LLC | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Strongbridge US Inc. | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Philips North America LLC | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
How this compares
$2,391 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Tallahassee
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.